Latest news and press releases about Polyrizon Ltd. (PLRZ): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue.
Price
| Price | $10.65 |
| Market Cap | $12M |
| Exchange | NASDAQ |
| Country | IL |
Related companies: AIM · CYCN · KTTA · NBY · PMCB · QNRX · RADX
Explore sector: Healthcare · Biotechnology
More sections of PLRZ: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks